Refine the list (min. 2 characters)
Keynote Presentation (In-Person)
Objective: Mineralocorticoid receptor antagonists (MRAs) are indicated for several cardiovascular (CV) conditions, including heart failure (HF) and hypertension (HTN). However, adverse drug reactions or dose-limiting side-effects may lead to discontinuation. We aimed to descri [....] » Read More
Keynote Presentation (In-Person)
Title: Diabetic cardiomyopathy and metal-mediated inflammation and cell deaths
Cardiac inflammation and myocyte death are essential for initiating the pathogenesis and progression of various etiological cardiomyopathies, including diabetic cardiomyopathy (DCM), reported in 1972. Cardiac cell death was detected in the hearts of patients with diabetes and ani [....] » Read More
Keynote Presentation (Virtual)
Background: Atrial fibrillation (AF) is the most common form of arrhythmia and is a growing clinical problem. Post-translational modifications (PTMs) constitute crucial epigenetic mechanisms but modification of lysine 2-hydroxyisobutyrylation (Khib) in AF is still unknown. This s [....] » Read More
Keynote Presentation (Virtual)
Health and social care systems around the world undergo a transformation towards personalized, preventive, predictive, participative precision medicine (5PM), considering the individual health status, conditions, genetic and genomic dispositions in personal, social, occupational, [....] » Read More
Oral Presentation (In-Person)
Background and Objective: Early diagnosis and cardioprotection remain key challenges in the management of inflammatory and chemotherapy-induced cardiac injuries. To address these, our research team has developed macrophage membrane-modified nanoparticles (MM/NPs) to guide early n [....] » Read More
Oral Presentation (Virtual)
Background: Biomaterials used as grafts in coronary artery bypass grafting (CABG) surgery are autologous arteries (internal mammary artery [IMA] and radial artery [RA]) and saphenous vein (SV). In this study, we investigated the biological differences among IMA-SV, RA-SV, and IMA [....] » Read More
Oral Presentation (Virtual)
Title: Laser catheter ablation of long-lasting chronic persistent atrial fibrillation (AF)
Graphical abstract: High Density (HD) lasermapping guided AF ablation: gradual abatement of local atrial potential amplitudes (AA1) with abolishment in 4s. This 7th laser impact aimed at the posterior left atrial wall achieved recurrence to sinus rhythm (SR) A2A3 in the 8th se [....] » Read More
Oral Presentation (Virtual)
Atrial fibrillation (AF) is the most common arrhythmia. It is known leading cause of ischemic cerebrovascular accidents. Yasser’s fibrillation (sinusoidal AF) or mixed AF is a new cardiovascular discovery. The partial sino-atrial nodal function has an essential role in the [....] » Read More
Poster Presentation (In-Person)
Background: Atrial fibrillation (AF) is the most common sustained arrhythmia and a major contributor to global morbidity and mortality. Although antiarrhythmic drugs and catheter ablation have advanced AF management, their effectiveness remains limited. Fulvning Granules (FLN), a [....] » Read More
Poster Presentation (In-Person)
Aims: To provide novel insights into the diagnosis of atrial fibrillation (AF), we aimed to identify mitochondria-associated endoplasmic reticulum membranes (MAMs)-related biomarkers for AF. Methods: A comprehensive analysis was conducted to identify MAM-related biom [....] » Read More
Poster Presentation (Virtual)
Objective: To developed a hybrid resting full-cycle ratio (RFR)- fractional flow reserve (FFR) decision-making approach for physiology-guided coronary revascularization in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). Materials and methods: This [....] » Read More
Copyright 2024 Mathews International LLC All Rights Reserved